964 results match your criteria csdh


Pharmacological Treatment in the Management of Chronic Subdural Hematoma.

Front Aging Neurosci 2021 1;13:684501. Epub 2021 Jul 1.

Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China.

Several pharmacological treatments have been used to treat patients with chronic subdural hematoma (CSDH), although little is known about the comparative effectiveness of different classes of medication. We performed a Bayesian network meta-analysis to compare and rank the efficacy and safety of five drug regimens to determine the best treatment for this group of patients. We systematically searched PubMed, Medline, clinicaltrials. Read More

View Article and Full-Text PDF

Efficacy of the Direct Aspiration-Irrigation Maneuver for the Treatment of Chronic Subdural Hematoma: A Single Hospital's Experience.

Cureus 2021 Jul 7;13(7):e16231. Epub 2021 Jul 7.

Neurosurgery, Shidong Hospital of Yangpu District, Shanghai, CHN.

Objective The traditional methods for managing symptomatic chronic subdural hematoma (CSDH) at our hospital include evacuation via single burr-hole irrigation with continuous closed subdural drainage (SBID). The single burr-hole aspiration and irrigation technique with continuous closed subdural drainage (SBAID) is an attractive alternative method. The goal of this study was to evaluate the radiographic and clinical outcomes of SBAID compared with traditional SBID methods. Read More

View Article and Full-Text PDF

Local Skull Thinning is One of Risks for the Ruptured Arachnoid Cysts With Chronic Subdural Hematoma in Adults: Thirty-two Clinical Reports.

J Craniofac Surg 2021 Jul 13. Epub 2021 Jul 13.

Department of Neurosurgery, Beijing TianTan Hospital, Capital Medical University, Beijing Department of Neurosurgery, the First Affiliated Hospital of Anhui Medical University, Hefei China National Clinical Research Center for Neurological Diseases Beijing Key Laboratory of Central Nervous System Injury and Department of Neurosurgery, Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Objective: Chronic subdural hematomas (CSDHs) in young people are uncommon, rupture of arachnoid cysts (ACs) is one of the reasons for young patients. The detailed features of CSDHs associated with ACs remain poorly understood. The objective of this study is to analyze the characteristics of risks for the rupture of ACs with CSDH in Adults. Read More

View Article and Full-Text PDF

Relevance of comorbidities and antithrombotic medication as risk factors for reoperation in patients with chronic subdural hematoma.

Neurosurg Rev 2021 Jul 9. Epub 2021 Jul 9.

Department of Neurosurgery, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.

In an aging Western society, the incidence of chronic subdural hematomas (cSDH) is continuously increasing. In this study, we reviewed our clinical management of cSDH patients and identified predictive factors for the need of reoperation due to residual or recurrent hematomas with a focus on the use of antithrombotic drugs. In total, 623 patients who were treated for cSDH with surgical evacuation between 2006 and 2016 at our department were retrospectively analyzed. Read More

View Article and Full-Text PDF

A matter of frailty: the modified Subdural Hematoma in the Elderly (mSHE) score.

Neurosurg Rev 2021 Jul 6. Epub 2021 Jul 6.

Department of Neurosurgery, Universitätsmedizin Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.

The Subdural Hematoma in the Elderly (SHE) score was developed as a model to predict 30-day mortality from acute, chronic, and mixed subdural hematoma in the elderly population after minor or no trauma. Emerging evidence suggests frailty to be predictive of mortality and morbidity in the elderly. In this study, we aim to externally validate the SHE for chronic subdural hematoma (CSDH) alone, and we hypothesize that the incorporation of frailty into the SHE may increase its predictive power. Read More

View Article and Full-Text PDF

The Crucial Role of Eosinophils in the Life Cycle, Radiographical Architecture, and Risk of Recurrence of Chronic Subdural Hematomas.

Neurotrauma Rep 2021 8;2(1):76-83. Epub 2021 Feb 8.

Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

Chronic subdural hematomas (CSDHs) are a common neurological condition, whose incidence is expected to increase with an aging population. Although surgical evacuation is the mainstay of treatment, it results in a recurrence requiring reoperation (RrR) in 3-30% of cases. Recurrence is thought to be driven by a combination of inflammatory and angiogenic processes occurring within the CSDH outer membrane. Read More

View Article and Full-Text PDF
February 2021

-infected chronic subdural hematoma mimicking an expanding hematoma: A case report.

Surg Neurol Int 2021 14;12:288. Epub 2021 Jun 14.

Department of Neurosurgery, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.

Background: We present the rare case of a spontaneous intracranial subdural empyema caused by in a preexisting chronic subdural hematoma (CSDH).

Case Description: A 72-year-old man with a history of the right CSDH that remained radiologically unchanged for the past 2 years with conservative management was transferred to our hospital because of fever and convulsive seizure. Systemic sources of infection were not identified. Read More

View Article and Full-Text PDF

Pediatric middle meningeal artery embolization for chronic subdural hematoma: A case report.

Surg Neurol Int 2021 25;12:239. Epub 2021 May 25.

Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.

Background: The most common neuroradiological finding in pediatric nonaccidental trauma (NAT) is subdural hematoma (SDH). Management options for pediatric SDH range from conservative clinical surveillance to craniotomy or decompressive craniectomy. The middle meningeal artery (MMA) indirectly feeds the hematoma; thus, MMA embolization is an alternative or adjunct to current surgical treatments in adults. Read More

View Article and Full-Text PDF

Intraoperative hematoma volume can predict chronic subdural hematoma recurrence.

Surg Neurol Int 2021 25;12:232. Epub 2021 May 25.

Department of Neurosurgery, Shunan Memorial Hospital, Kudamatsu, Yamaguchi, Japan.

Background: We routinely measured the exact chronic subdural hematoma (CSDH) volume during single burr hole surgery. To date, several risk factors have been reported for CSDH recurrence, including sex, hematoma volume and degree of midline shift calculated from computed tomography, use of anticoagulants or antiplatelet medications, and alcohol consumption habits. The aim of this study was to clarify whether hematoma volume, in conjunction with other factors, can predict recurrence. Read More

View Article and Full-Text PDF

Middle Meningeal Artery Embolization for Chronic Subdural Hematoma: A national database study of 191 patients in the United States.

World Neurosurg 2021 Jun 29. Epub 2021 Jun 29.

Department of Neurosurgery, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555, USA. Electronic address:

Background: Middle meningeal artery embolization (MMAE) has been used as an effective minimally invasive treatment for chronic subdural hematomas (cSDH). The demographics and clinical outcomes after MMAE treatment for cSDH have not yet been studied using the large scale of a national database.

Methods: We queried all MMAE cases up to October 7, 2020, from the TriNetX Analytics Network. Read More

View Article and Full-Text PDF

Comparative Study of Subgaleal and Subdural Closed Drain in Surgically Treated Cases of Chronic Subdural Hematoma.

Asian J Neurosurg 2021 Jan-Mar;16(1):96-98. Epub 2021 Feb 23.

Department of Neurosurgery, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.

Background: Chronic subdural hematoma (CSDH) is seen most common in geriatric patients, and trauma is the most important reason for CSDH. Operative treatment of CSDH in symptomatic patients is yet the gold standard of therapy because it allows decompression of the subdural space and aids improvement in neurological status. Burr-hole craniostomy is the most common accepted treatment for CSDH. Read More

View Article and Full-Text PDF
February 2021

Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis.

J Neurointerv Surg 2021 Jun 30. Epub 2021 Jun 30.

Department of Neurological Surgery, University of Louisville School of Medicine, Louisville, Kentucky, USA

Middle meningeal artery (MMA) embolization has been proposed as a minimally invasive treatment for chronic subdural hematoma (cSDH). The aim of this systematic review and meta-analysis is to compare outcomes after MMA embolization versus conventional management for cSDH. We performed a systematic review of PubMed, Embase, Oxford Journal, Cochrane, and Google Scholar databases from April 1987 to October 2020 in accordance with PRISMA guidelines. Read More

View Article and Full-Text PDF

Efficacy and mid-term outcome of middle meningeal artery embolization with or without burr hole evacuation for chronic subdural hematoma compared with burr hole evacuation alone.

J Neurointerv Surg 2021 Jun 29. Epub 2021 Jun 29.

Department of Diagnostic and Interventionell Radiology and Neuroradiology, University Hospital Augsburg, Augsburg, Bavaria, Germany.

Background: Chronic subdural hematoma (CSDH) is a common neurosurgical condition with high recurrence rates. Repeated microbleedings from fragile neo-vessels supplied by peripheral branches of the middle meningeal artery (MMA) are believed to be responsible for the growth and recurrence of CSDH. Thus, MMA embolization might be a promising method to prevent re-bleedings and recurrences. Read More

View Article and Full-Text PDF

Incidence of chronic subdural haematoma: a single-centre exploration of the effects of an ageing population with a review of the literature.

Acta Neurochir (Wien) 2021 Jun 28. Epub 2021 Jun 28.

Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, UK.

Background: Chronic subdural haematoma (cSDH) is a common neurosurgical pathology frequently occurring in older patients. The impact of population ageing on cSDH caseload has not been examined, despite relevance for health system planning.

Methods: This is a single-centre study from the UK. Read More

View Article and Full-Text PDF

Middle Meningeal Artery Embolization Versus Conventional Treatment of Chronic Subdural Hematomas.

Neurosurgery 2021 Jun 25. Epub 2021 Jun 25.

Neurosurgery Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

Background: Middle meningeal artery (MMA) embolization is an emerging minimally invasive endovascular technique for chronic subdural hematoma (cSDH). Currently, limited literature exists on its safety and efficacy compared with conventional treatment (open-surgical-evacuation-only).

Objective: To compare MMA embolization to conventional treatment. Read More

View Article and Full-Text PDF

Spontaneous chronic subdural hematoma due to cerebral cortical artery rupture: First case report and review of pertinent literature.

Neuroradiol J 2021 Jun 21:19714009211026891. Epub 2021 Jun 21.

Kaiser Permanente, USA.

Introduction: Chronic subdural hematoma (CSDH) is generally attributed to pathological changes in the dural arterial system, which has led to growing utilization of middle meningeal artery (MMA) embolization in CSDH treatment. There are no case reports of CSDH due to cerebral cortical artery perforation.

Method: We report a case of spontaneous CSDH caused by cortical artery rupture that was identified on digital subtraction angiography and could be visualized on computed tomographic angiography (CTA). Read More

View Article and Full-Text PDF

Middle meningeal artery embolization for postoperative supratentorial chronic subdural hematoma occurring after posterior fossa neurosurgery.

J Cerebrovasc Endovasc Neurosurg 2021 Jun 18;23(2):152-158. Epub 2021 Jun 18.

Department of Neurosurgery, Seoul National University Hospital, Seoul, Korea.

Chronic subdural hematoma (CSDH) after posterior fossa surgery is rare but may occur. A 70-year-old man with trigeminal neuralgia underwent microvascular decompression. The patient took several medications for trigeminal neuralgia and tremor for a long time. Read More

View Article and Full-Text PDF

Impact of time to resumption of antithrombotic therapy on outcomes after surgical evacuation of chronic subdural hematoma: A multicenter cohort study.

J Clin Neurosci 2021 Jul 1;89:389-396. Epub 2021 Jun 1.

Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Neurosurgery, Department of Surgery, National University Hospital, National University Health System, Singapore.

Background: The decision to resume antithrombotic therapy after surgical evacuation of chronic subdural hematoma (CSDH) requires judicious weighing of the risk of bleeding against that of thromboembolism. This study aimed to investigate the impact of time to resumption of antithrombotic therapy on outcomes of patients after CSDH drainage.

Methods: Data were obtained retrospectively from three tertiary hospitals in Singapore from 2010 to 2017. Read More

View Article and Full-Text PDF

Chronic subdural hematoma in patients over 65 years old: Results of using a postoperative cognitive evaluation to determine whether to permit return to driving.

Surg Neurol Int 2021 10;12:212. Epub 2021 May 10.

Department of Rehabilitation, Kesennuma City Hospital, Kesennuma, Miyagi, Japan.

Background: Chronic subdural hematoma (CSDH) is usually associated with good recovery with burr hole irrigation and postoperative drainage under local anesthesia. In Japan, traffic accidents by the elderly drivers over 65 years old are severely increasing, and there is no consensus on whether or not to return to driving after CSDH treatment. We perform a postoperative cognitive assessment. Read More

View Article and Full-Text PDF

Do statins reduce the rate of revision surgery after chronic subdural hematoma drain?

Acta Neurochir (Wien) 2021 Jul 25;163(7):1843-1848. Epub 2021 May 25.

Department of Neurosurgery, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.

Background: With chronic subdural hematoma (CSDH), surgery is the therapeutic mainstay for large or symptomatic cases. Statins are reported to be effective as the primary therapy of CSDH to obviate the need for surgery. However, the effect of statins on the postoperative course of CSDH is largely unclear. Read More

View Article and Full-Text PDF

The Mini-Craniotomy for cSDH Revisited: New Perspectives.

Front Neurol 2021 6;12:660885. Epub 2021 May 6.

Department of Neurological Surgery, University of California, Irvine, Orange, CA, United States.

Chronic subdural hematomas (cSDH) are increasingly prevalent worldwide with the increased aging population and anticoagulant use. Different surgical, medical, and endovascular treatments have had varying success rates. Primary neurosurgical interventions include burr hole drainage of the cSDH and mini-craniotomies/craniotomies with or without fenestration of the inner membrane. Read More

View Article and Full-Text PDF

Perioperative prophylactic middle meningeal artery embolization for chronic subdural hematoma: a series of 44 cases.

J Neurosurg 2021 May 21:1-9. Epub 2021 May 21.

Objective: Chronic subdural hematoma (cSDH) is a common and challenging pathology to treat due to both the historically high recurrence rate following surgical evacuation and the medical comorbidities inherent in the aging patient population that it primarily affects. Middle meningeal artery (MMA) embolization has shown promise in the treatment of cSDHs, most convincingly to avoid surgical evacuation in relatively asymptomatic patients. Symptomatic patients requiring surgical evacuation may also benefit from perioperative MMA embolization to prevent cSDH recurrence. Read More

View Article and Full-Text PDF

Middle Meningeal Artery Embolization of a Pediatric Patient With Progressive Chronic Subdural Hematoma.

Oper Neurosurg (Hagerstown) 2021 May 6. Epub 2021 May 6.

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Background And Importance: Evidence suggests middle meningeal artery (MMA) embolization benefits adult patients with chronic subdural hematoma (CSDH) at high risk for recurrence or hemorrhagic complications. Yet, there has not been any report discussing MMA embolization in the pediatric population. Thus, we present a case of an infant with CSDH successfully managed with MMA embolization without surgical management. Read More

View Article and Full-Text PDF

A novel rat model of chronic subdural hematoma: Induction of inflammation and angiogenesis in the subdural space mimicking human-like features of progressively expanding hematoma.

Brain Res Bull 2021 Jul 28;172:108-119. Epub 2021 Apr 28.

Department of Neurosurgery, Tianjin Medical University General Hospital, 154 Anshan Road, Tianjin, 300052, China; Tianjin Neurological Institute, Key Laboratory of Post-Neuroinjury Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, 154 Anshan Road, Tianjin, 300052, China. Electronic address:

Pathophysiological mechanisms of chronic subdural hematoma (CSDH) involve localized inflammation, angiogenesis, and dysregulated coagulation and fibrinolysis. The scarcity of reproducible and clinically relevant animal models of CSDH hinders further understanding the underlying pathophysiology and improving new treatment strategies. Here, we developed a novel rat model of CSDH using extracellular matrices (Matrigel) and brain microvascular endothelial cell line (bEnd. Read More

View Article and Full-Text PDF

Predictors of Brain Natriuretic Peptide Serum Level Elevation in Patients with Symptomatic Chronic Subdural Hematoma: A Prospective Study.

J Clin Med 2021 Apr 20;10(8). Epub 2021 Apr 20.

Department of Orthopedics and Trauma Surgery, St Vinzenz Hospital Dinslaken, University of Duisburg-Essen, 46537 Dinslaken, Germany.

Background: Brain natriuretic peptide serum levels (BNP) on admission are frequently elevated in patients with symptomatic chronic subdural hematoma (cSDH) and predict unfavorable long-term functional outcomes. However, the reasons for these elevated levels remain unclear. Therefore, we aimed to identify the predictors of BNP elevation. Read More

View Article and Full-Text PDF

The validity of the simple methods of estimating chronic subdural hematoma volume.

Neurochirurgie 2021 Apr 26. Epub 2021 Apr 26.

Department of Neurosurgery, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.

Objectives: It was reported that the XYZ/2 technique (using length, width and height of hematoma) is a simple and reliable method of estimation of chronic subdural hematoma volume. Two subtypes of techniques enable to adequately estimate, it is unclear which is more accurate. Computer-assisted volumetric analysis is widely considered the gold standard for CSDH volumetric analysis. Read More

View Article and Full-Text PDF

Middle meningeal artery embolization with subdural evacuating port system for primary management of chronic subdural hematomas.

Neurosurg Rev 2021 Apr 24. Epub 2021 Apr 24.

Department of Neurosurgery, MedStar Georgetown University Hospital, 3800 Reservoir Road NW, PHC7, Washington, DC, USA.

Optimal treatment for chronic subdural hematomas remains controversial and perioperative risks and comorbidities may affect management strategies. Minimally invasive procedures are emerging as alternatives to the standard operative treatments. We evaluate our experience with middle meningeal artery (MMA) embolization combined with Subdural Evacuating Port System (SEPS) placement as a first-line treatment for patients with cSDH. Read More

View Article and Full-Text PDF

Modified Computed Tomography Classification for Chronic Subdural Hematoma Features Good Interrater Agreement: A Single-Center Retrospective Cohort Study.

World Neurosurg 2021 Jul 20;151:e407-e417. Epub 2021 Apr 20.

Department of Neurosurgery, Jikei University School of Medicine, Minato-ku, Tokyo, Japan.

Objective: The present study aimed to establish whether our modified Nakaguchi computed tomography (CT) classification improves the interrater agreement of chronic subdural hematoma (CSDH) classification and prediction of CSDH recurrence relative to 2 other CT classifications.

Methods: This retrospective study considered 277 consecutive patients with CSDH and 307 hematomas treated with burr-hole surgery between January 2009 and December 2018. Two neurosurgeons blinded to patients' clinical data classified the CT scans of patients with CSDH into 4 or 5 types according to the Nomura classification (high, iso, low, mixed, and layering), Nakaguchi classification (homogenous, laminar, separated, and trabecular), and our modified Nakaguchi classification (homogenous, gradation, laminar, separated, and trabecular). Read More

View Article and Full-Text PDF

Postoperative neutrophil-to-lymphocyte ratio variation is associated with chronic subdural hematoma recurrence.

Neurol Sci 2021 Apr 23. Epub 2021 Apr 23.

Department of Neurology, Division of Neurosurgery, Neurotrauma Unit, Hospital das clinicas, University of São Paulo Medical School, São Paulo, Brazil.

Introduction: Chronic subdural haematoma (CSDH) is one of the most common neurosurgical pathologies. The recurrence of chronic subdural haematomas is an important concern, considering that elderly patients are the most affected and reoperations in these patients may represent a risk of neurological and clinical complications. In accordance with the inflammatory theory regarding CSDH and its recurrence, we aimed to evaluate the role of an inflammatory marker, neutrophil-to-lymphocyte ratio (NLR), as a risk factor and prognostic variable for CSDH recurrence. Read More

View Article and Full-Text PDF

Minimally Invasive Approach to Subdural Hematoma Treatment Using IRRAflow Catheter and Middle Meningeal Artery Embolization.

Cureus 2021 Mar 18;13(3):e13979. Epub 2021 Mar 18.

Neurosurgery, University at Buffalo, Buffalo, USA.

Chronic subdural hematoma (cSDH) is a common neurosurgical pathology that usually occurs in the seventh decade of life. Patients can present with mental status changes, focal neurologic deficits, seizures, headaches, or may be asymptomatic. Recurrence is common. Read More

View Article and Full-Text PDF